skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hello,markets are looking real good,i'am thinking Trump will need some good news shortly to keep it going?It looks like the establishment is circling.
VGG as a dividend ETF has a fairly low dividend, does it only rely on capital appreciation or a special dividend at year end?
Could you recommend a ETF along the same lines that pay 4-5% dividend,or stay with VGG.
Thanks,great work Brad
Read Answer Asked by Brad on February 15, 2017
Q: Hello 5i team,
I bought these 2 stocks roughly 3.5 years back. Vale was bought at $13 and slx was bought at $49. Both are picking up momentum and my question is whether I should get out when they approach my entry price and go with something else. slx is currently at $45 and vale at $12. I am more reluctant to part with slx since it covers the steel space but vale has a huge depth.

Or should I stay in and see how much they can appreciate?

Thanks,
Andrew
Read Answer Asked by Andrew on February 14, 2017
Q: Looking to spread my Technology investments into US$ shares in one of these 3 positions. All seem to be doing extremely well and appear quite similar to each other. Share prices go from $128-$52-$17 and psychologically I have an aversion to paying over $100/share (I know there is no rational to that).
Would appreciate your analysis of these 3 and recommendation or any others in this arena.

thx
Rrichterr
Read Answer Asked by frederick on February 14, 2017
Q: Over the last 20 years CNR and KSU have been outstanding performers. CNR up about 2000% and KSU up 7500%!! Both have been better than Birkshire Hathaway. Which would pick for a long hold? Have the metrics of these RRs changed? In particular, does KSU still have the advantage that propelled it 20 years ago? It has lagged of late.
Read Answer Asked by Greg on February 13, 2017